You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Prognostic value for overall survival and locoregional recurrence of patient and tumor characteristics

From: Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients

Prognostic factors Overall survival Locoregional recurrence
n HR 95 % CI p n HR 95 % CI p
Age 118 1.0 (1.0;1.1) 0.02 112 1.0 (0.95;1.0) 0.89
Tumor size 117 1.0 (0.90;1.2) 0.62 111 1.0 (0.76;1.3) 0.99
Residual mass after resectiona         
 Yes 57     52    
 Possibly 27 0.81 (0.45;1.5) 0.49 27 0.83 (0.29;2.4) 0.73
 No 16 0.47 (0.20;1.1) 0.09 15 0.80 (0.22;2.9) 0.73
Tumor location         
 Not mobile part 27     25    
 Mobile part 91 1.05 (0.61;1.8) 0.85 87 0.85 (0.34;2.1) 0.73
Clinical lymph node involvement         
 No 109     103    
 Yes 9 0.52 (0.19;1.4) 0.20 9 1.5 (0.44;5.0) 0.53
Hydronephrosis         
 No 97     92    
 Yes 21 1.29 (0.73;2.3) 0.38 20 2.9 (1.2;6.8) 0.01
Tumor stage         
 T2-T3 108     103    
 T4 10 1.05 (0.45;2.4) 0.91 9 0.52 (0.07;3.8) 0.23
  1. NB. Due to exclusion of patients receiving less than their prescribed dose for the analysis on local recurrence, total amount of patients in this analysis is 112, which is different from the analysis on overall survival. In addition, residual mass after resection and tumor size were not known for all patients
  2. aAs assessed on the CT scan made for planning purposes